The Function of PPARα in Cancer Drug Development: A Promising Target for Cancer Treatment

Cancer is one of the leading causes of mortality globally. PPAR modulators may hold great potential for the management of cancer patients. PPAR modulators also activate specific transcriptional pathways, regulate immune responses and inflammation, and influence the proliferation of various cancer cell types. In the last decade, emerging evidence has shown that PPARα, a nuclear hormone receptor, can modulate carcinogenesis via exerting effects on one or several characteristic pathological behaviors of cancer. This review summarizes current knowledge of PPARα function in various aspects of cancer development and the modulators that regulate PPARα. Based on the current knowledge, we have discussed the development of a potential modulator targeting PPARα for cancer treatment.

Authors

Institutions

Publication Details

Journal
Current Cancer Drug Targets
Published
2026-04-17
DOI
https://doi.org/10.2174/0115680096423510251031065737
Primary Topic
Peroxisome Proliferator-Activated Receptors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Function of PPARα in Cancer Drug Development: A Promising Target for Cancer Treatment

Ragothaman Prathiviraj, Mohammed Qasim Waheeb, Rasiravathanahalli Kaveriyappan Govindarajan, Igor Rzhepakovsky et al.
Current Cancer Drug Targets
Peroxisome Proliferator-Activated Receptors
article

The Function of PPARα in Cancer Drug Development: A Promising Target for Cancer Treatment

Ragothaman Prathiviraj, Mohammed Qasim Waheeb, Rasiravathanahalli Kaveriyappan Govindarajan, Igor Rzhepakovsky, Mohammed A. Al-Duais, Sergey Povetkin, Chellasamy Panneerselvam, Hans-Uwe Dahms, Abdulrahman Asmari
article en

Abstract

Cancer is one of the leading causes of mortality globally. PPAR modulators may hold great potential for the management of cancer patients. PPAR modulators also activate specific transcriptional pathways, regulate immune responses and inflammation, and influence the proliferation of various cancer cell types. In the last decade, emerging evidence has shown that PPARα, a nuclear hormone receptor, can modulate carcinogenesis via exerting effects on one or several characteristic pathological behaviors of cancer. This review summarizes current knowledge of PPARα function in various aspects of cancer development and the modulators that regulate PPARα. Based on the current knowledge, we have discussed the development of a potential modulator targeting PPARα for cancer treatment.

Current Cancer Drug TargetsVol. 26
Kaohsiung Medical University (TW), Pondicherry University (IN), North-Caucasus Federal University (RU), Al-Muthanna University (IQ), Karpagam Academy of Higher Education (IN), University of Tabuk (SA)
Good health and well-being
Openalex Percentile: Top 10%
Peroxisome Proliferator-Activated Receptors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.